Bioequivalence of Kuhnil Propiverine Hydrochloride Tablet to BUP-4 Tablet (Propiverine Hydrochloride 20 mg)
![]() |
Cho, Hea-Young
(Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Park, Eun-Ja (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Baek, Seung-Hee (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Kim, Se-Mi (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Park, Chan-Ho (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Oh, In-Joon (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) Moon, Jai-Dong (Medical School, Chonnam National University) Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University) |
1 | G. Franke, F. Schnabel, A. Weinbrenner, K. Richter, T. Gramatt and W. Siegmud, Steady-state disposition of the bladder spasmolytics propiverine is circadian time dependent in man, Eur. J. Clin. Pharmacal., 56, 93(26) (2000) |
2 | A. Wengler, T. Schneider, M. Zschiesche and W. Siegmud, Undersuchungen zwm metabolismus des blasenspasmolytikums propiverine (mictonorm) beim menschen, Pharmazie., 43, 652-653 (1988) |
3 | K. Hanaoka, T. Kugimiya and Y. Inada, Phase I study of propiverine hydrochloride. The 2nd report: repeated oral dosing study, Jpn. J. Clin. Pharmacol. Ther., 21, 567-568 (1990) DOI |
4 | P. Meisel, S. Langner and W. Siegmud, In-vivo binding of propiverine hydrochloride and some of its metabolites to serum albumin in man, J. Pharm. Pharmaco., 49, 270-272 (1997) DOI ScienceOn |
5 | Martindale, The complete drug reference, 32 edition 1999, 61 (1999) |
6 | Japan pharmaceutical information center : Drug in Japan - Ethical drugs, 25 edition, 1894-1896 (2002) |
7 | I. Komoto, K. Yoshida, E. Matsushima, K. Yamashita, T. Aikawa and S. Akashi, Validation of a simple liquid chromatography-tendem mass spectrometric method for the determination of propiverine hydrochloride and its N-oxide metabolism in human plasma, J. Chromatagr. B; 799(1), 141-147 (2004) DOI ScienceOn |
8 |
H. Madersbacher and G. M |
9 | K.O. Haustein and G. Huller, On the pharmacokinetics and metabolism of propiverine in man, Eur. J. Drug Metab. Pharmacokinet., 13(2), 81-90 (1988) DOI |
10 |
R. Walter, C. Ullmann, D. Th |
11 | Food and Drug Administration (FDA): Guidance for Industry; Waiver of in vivo bioavailability and bioequivalence study for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Center for Drug Evaluation and Research (CDER), August (2000) |
12 | 염산프로피베린 제제의 생물학적동등성시험 지침, 식품의약품안전청 독성연구원 의약품동등성평가과 (2003. 1) |
13 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |
14 | 식품의약품안전청 고시 제 1999-67호, 의약품임상시험관리기준 (2000. 1. 4) |
![]() |